Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: to be included in the trial the participant must: 1. have given written informed consent to participate 2. be aged 18 years to 70 years 3. not previously have been diagnosed with covid-19 4. work in a high-risk secondary or tertiary healthcare setting (hospitals accepting covid-19 patients) with direct patient-facing care

inclusion criteria: to be included in the trial the participant must: 1. have given written informed consent to participate 2. be aged 18 years to 70 years 3. not previously have been diagnosed with covid-19 4. work in a high-risk secondary or tertiary healthcare setting (hospitals accepting covid-19 patients) with direct patient-facing care

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: to be included in the trial the participant must: have given written informed consent to participate be aged 18 years to 70 years not previously have been diagnosed with covid-19 work in a high-risk secondary or tertiary healthcare setting (hospitals accepting covid-19 patients) with direct patient-facing care

inclusion criteria: to be included in the trial the participant must: have given written informed consent to participate be aged 18 years to 70 years not previously have been diagnosed with covid-19 work in a high-risk secondary or tertiary healthcare setting (hospitals accepting covid-19 patients) with direct patient-facing care

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: to be included in the trial the participant must: 1. have given written informed consent to participate 2. be aged 18 years to 70 years 3. not previously have been diagnosed with covid-19 4. work in a high-risk secondary or tertiary healthcare setting (hospitals accepting covid-19 patients) with direct patient-facing care

inclusion criteria: to be included in the trial the participant must: 1. have given written informed consent to participate 2. be aged 18 years to 70 years 3. not previously have been diagnosed with covid-19 4. work in a high-risk secondary or tertiary healthcare setting (hospitals accepting covid-19 patients) with direct patient-facing care